A tailored phosphorothioate coordinator enables CRISPR/Cas in-situ amplification
Nucleic Acids Research · 24.02.2026 · 54 (5)
DOI: 10.1093/nar/gkag187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 03.03.2026. Verfasst von Tiantian Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Clinical Molecular Medical Detection, Innovative and Translational Laboratory of Molecular Diagnostics, Laboratory Medicine Center, Th…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, CRISPR-Associated Proteins, Phosphorothioate Oligonucleotides, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Chongqing Education Commission, New Chongqing Youth Innovative Talents Project.
Abstract (Originalsprache)
The CRISPR/Cas system is a powerful tool for molecular diagnostics, but its reliance on linear amplification constrains sensitivity, particularly for in situ imaging. Here, we discovered that phosphorothioate (PS)-modified activators can modulate Cas enzyme conformation via hydrophobic anchoring. By adjusting the PS modification sites, we achieved precise control over Cas activation and trans-cleavage resistance. Guided by this mechanism, we proposed a tailored design strategy featuring a “scattered” PS modification to engineer a linear “Coordinator” probe. This design effectively decouples Cas enzyme activation from substrate trans-cleavage resistance, enabling the construction of a Scattered PS Nucleic Acid-driven Cas Autocatalytic system (SACA). SACA achieves exponential amplification without external enzymes, enhancing Cas12a and Cas13a sensitivity by 50 000-fold and 10 000-fold, respectively. Furthermore, the superior biostability and structural simplicity of these linear probes endow SACA with excellent compatibility, facilitating precise in situ imaging of HPV16 and HPV18 mRNA in cervical cancer cells. This study not only advances the understanding of Cas enzyme regulation by chemically modified nucleic acids but also establishes a new paradigm for precise and efficient molecular diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Center for Clinical Molecular Medical Detection, Innovative and Translational Laboratory of Molecular Diagnostics, Laboratory Medicine Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing…
- The Biobank Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R.China.
- Institute of Bioengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, Zhejiang 310027, P.R.China.
- ZJU-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou, Zhejiang 311200, P.R.China.
- Zybio Inc, Chongqing 400082, P.R.China.
ORCID-Profile: Wei Cheng
Förderung
- National Natural Science Foundation of China
- Chongqing Education Commission
- New Chongqing Youth Innovative Talents Project
Zitieren
APA
Yang, T., Tang, M., Xu, L., Jiang, L., Jiang, L., Zou, Y., Wang, J., Liu, Z., Chen, F., Ban, Y., Ren, W., & Cheng, W. (2026). A tailored phosphorothioate coordinator enables CRISPR/Cas in-situ amplification. Nucleic Acids Research, 54(5). https://doi.org/10.1093/nar/gkag187
Vancouver
Yang T, Tang M, Xu L, Jiang L, Jiang L, Zou Y, et al. A tailored phosphorothioate coordinator enables CRISPR/Cas in-situ amplification. Nucleic Acids Research. 2026;54(5). doi:10.1093/nar/gkag187
BibTeX
@article{Yang2026,
author = {Yang, Tiantian and Tang, Man and Xu, Li and Jiang, Lanxin and Jiang, Ling and Zou, Yuting and Wang, Jing and Liu, Zhangling and Chen, Fengjiao and Ban, Yanna and Ren, Wenlong and Cheng, Wei},
title = {A tailored phosphorothioate coordinator enables CRISPR/Cas in-situ amplification},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {5},
doi = {10.1093/nar/gkag187}
}
EUVIMED